Management strategy for women of reproductive age with undifferentiated connective tissue dysplasia
Perm Medical Journal · 07.11.2026 · 43 (5) · 63-71
DOI: 10.17816/pmj43563-71 ↗Kurz gefasst
Fachartikel in der Zeitschrift Perm Medical Journal, online erschienen am 07.11.2026. Verfasst von M. Y. Smetanin und 5 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Objective
To develop a patient-centered management strategy for women of reproductive age with undifferentiated connective tissue dysplasia (UCTD) and to evaluate its impact on quality of life and reproductive attitude. Materials and methods. The randomized study included 88 women of reproductive age with UCTD and hypomagnesemia and hypovitaminosis D. The control group consisted of 100 apparently healthy women without signs of UCTD. Patients with UCTD received Magnerot and Fortedetrim for 8 weeks. Serum vitamin D (25(OH)D) levels, magnesium levels in serum and oral fluid, autonomic status, anxiety and depression levels, quality of life, and reproductive attitude were assessed. A management strategy for women of reproductive age with UCTD was proposed, including diet therapy, psychotherapy, graded physical exercise, magnesium and vitamin D supplements, and a «School for patients with UCTD».
Results
The use of Magnerot and Fortedetrim for 8 weeks significantly reduced trait anxiety, depressive symptoms, and autonomic disorders, and improved quality of life scores and Childbearing Role Orientations Questionnaire (CROQ) scores (p 0.05). One-way analysis of variance (ANOVA) and regression analysis confirmed a significant effect of anxiety level (Hospital Anxiety and Depression Scale – Anxiety subscale, HADS-A) on reproductive attitude (RA): (RA = 80.15 – (5.51·HADS), R2 = 0.67), which made it possible to assess treatment effectiveness using the HADS-A, as it is less time-consuming for clinical practice than the CROQ, since patients needed to answer 14 questions (versus 40 in the CROQ).
Conclusions
The developed management strategy for women of reproductive age with UCTD, through correction of magnesium and vitamin D deficiency, allows improvement of psychological status, autonomic profile, and quality of life indicators, and positively changes reproductive attitude, which overall may contribute to increasing their reproductive potential. The results justify the need for magnesium and vitamin D supplements in this category of patients.
Zitieren
APA
Smetanin, M. Y., Opolonsky, D. V., Bydanova, S. S., Pimenov, L. T., Chernyshova, T. E., & Loginova, E. N. (2026). Management strategy for women of reproductive age with undifferentiated connective tissue dysplasia. Perm Medical Journal, 43(5), 63-71. https://doi.org/10.17816/pmj43563-71
Vancouver
Smetanin MY, Opolonsky DV, Bydanova SS, Pimenov LT, Chernyshova TE, Loginova EN. Management strategy for women of reproductive age with undifferentiated connective tissue dysplasia. Perm Medical Journal. 2026;43(5):63-71. doi:10.17816/pmj43563-71
BibTeX
@article{Smetanin2026,
author = {Smetanin, M. Y. and Opolonsky, D. V. and Bydanova, S. S. and Pimenov, L. T. and Chernyshova, T. E. and Loginova, E. N.},
title = {Management strategy for women of reproductive age with undifferentiated connective tissue dysplasia},
journal = {Perm Medical Journal},
year = {2026},
volume = {43},
number = {5},
pages = {63--71},
doi = {10.17816/pmj43563-71}
}
EUVIMED